ShanghaiTech University Knowledge Management System
Potency Prediction of Covalent Inhibitors against SARS-CoV-2 3CL-like Protease and Multiple Mutants by Multiscale Simulations | |
2024-11-01 | |
发表期刊 | JOURNAL OF CHEMICAL INFORMATION AND MODELING
![]() |
ISSN | 1549-9596 |
EISSN | 1549-960X |
卷号 | 64期号:24 |
发表状态 | 已发表 |
DOI | 10.1021/acs.jcim.4c01594 |
摘要 | 3-Chymotrypsin-like protease (3CLpro) is a prominent target against pathogenic coronaviruses. Expert knowledge of the cysteine-targeted covalent reaction mechanism is crucial to predict the inhibitory potency of approved inhibitors against 3CLpros of SARS-CoV-2 variants and perform structure-based drug design against newly emerging coronaviruses. We carried out an extensive array of classical and hybrid QM/MM molecular dynamics simulations to explore covalent inhibition mechanisms of five well-characterized inhibitors toward SARS-CoV-2 3CLpro and its mutants. The calculated binding affinity and reactivity of the inhibitors are highly consistent with experimental data, and the predicted inhibitory potency of the inhibitors against 3CLpro with L167F, E166V, or T21I/E166V mutant is in full agreement with IC50s determined by the accompanying enzymatic assays. The explored mechanisms unveil the impact of residue mutagenesis on structural dynamics that communicates to change not only noncovalent binding strength but also covalent reaction free energy. Such a change is inhibitor dependent, corresponding to varied levels of drug resistance of these 3CLpro mutants against nirmatrelvir and simnotrelvir and no resistance to the 11a compound. These results together suggest that the present simulations with a suitable protocol can efficiently evaluate the reactivity and potency of covalent inhibitors along with the elucidated molecular mechanisms of covalent inhibition. |
关键词 | Binding energy Molecular docking Structural dynamics Coronaviruses Covalent reaction Dynamics simulation Expert knowledge Hybrid QM/MM Inhibition mechanisms Multi-scale simulation Pathogenics Reaction mechanism Structure based drug designs |
URL | 查看原文 |
收录类别 | EI ; SCI |
语种 | 英语 |
资助项目 | National Natural Science Foundation of China["32071248","22277130","22307133","32301050"] |
WOS研究方向 | Pharmacology & Pharmacy ; Chemistry ; Computer Science |
WOS类目 | Chemistry, Medicinal ; Chemistry, Multidisciplinary ; Computer Science, Information Systems ; Computer Science, Interdisciplinary Applications |
WOS记录号 | WOS:001366395100001 |
出版者 | AMER CHEMICAL SOC |
EI入藏号 | 20244817447066 |
EI主题词 | Coronavirus |
EI分类号 | 102.1.2 ; 1106.1 ; 408 Structural Design ; 801.3 Colloid Chemistry |
原始文献类型 | Article in Press |
引用统计 | 正在获取...
|
文献类型 | 期刊论文 |
条目标识符 | https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/452316 |
专题 | 物质科学与技术学院 物质科学与技术学院_博士生 |
共同第一作者 | Tianqing Nie |
通讯作者 | Yechun Xu; Qiang Shao |
作者单位 | 1.School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China. 2.State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. 3.Lingang Laboratory, Shanghai 200031, China. 4.School of Physical Science and Technology, ShanghaiTech University, Shanghai 201210, China. 5.University of Chinese Academy of Sciences, Beijing 100049, China. |
推荐引用方式 GB/T 7714 | Muya Xiong,Tianqing Nie,Zhewen Li,et al. Potency Prediction of Covalent Inhibitors against SARS-CoV-2 3CL-like Protease and Multiple Mutants by Multiscale Simulations[J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING,2024,64(24). |
APA | Muya Xiong.,Tianqing Nie.,Zhewen Li.,Meiyi Hu.,Haixia Su.,...&Qiang Shao.(2024).Potency Prediction of Covalent Inhibitors against SARS-CoV-2 3CL-like Protease and Multiple Mutants by Multiscale Simulations.JOURNAL OF CHEMICAL INFORMATION AND MODELING,64(24). |
MLA | Muya Xiong,et al."Potency Prediction of Covalent Inhibitors against SARS-CoV-2 3CL-like Protease and Multiple Mutants by Multiscale Simulations".JOURNAL OF CHEMICAL INFORMATION AND MODELING 64.24(2024). |
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 |
修改评论
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。